EP1226150A4 - TADG-15: A CARCINOMA-OVEREXPRISED EXTRACELLULAR SERINE PROTEASE - Google Patents

TADG-15: A CARCINOMA-OVEREXPRISED EXTRACELLULAR SERINE PROTEASE

Info

Publication number: EP1226150A4
Authority: EP; European Patent Office
Prior art keywords: overexprised; tadg; carcinoma; serine protease; extracellular serine
Prior art date: 1999-10-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Other versions

Inventor

Timothy J O'brien

Hirotoshi Tanimoto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Arkansas at Fayetteville

University of Arkansas at Little Rock

Original Assignee

University of Arkansas at Fayetteville

University of Arkansas at Little Rock

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-20

Filing date

2000-10-20

Publication date

2005-05-25

1999-10-20Priority claimed from US09/421,213external-prioritypatent/US7022821B1/en

2000-10-20Application filed by University of Arkansas at Fayetteville, University of Arkansas at Little RockfiledCriticalUniversity of Arkansas at Fayetteville

2000-10-20Priority to EP07118615ApriorityCriticalpatent/EP1887082A3/en

2002-07-31Publication of EP1226150A1publicationCriticalpatent/EP1226150A1/en

2005-05-25Publication of EP1226150A4publicationCriticalpatent/EP1226150A4/en

StatusWithdrawnlegal-statusCriticalCurrent

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Pathology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Hospice & Palliative Care (AREA)
Physics & Mathematics (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EP00973739A1999-10-202000-10-20 TADG-15: A CARCINOMA-OVEREXPRISED EXTRACELLULAR SERINE PROTEASEWithdrawnEP1226150A4 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
EP07118615AEP1887082A3 (en)	1999-10-20	2000-10-20	TADG-15: An extracellular serine protease overexpressed in carcinomas

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US421213		1989-10-13
US09/421,213US7022821B1 (en)	1998-02-20	1999-10-20	Antibody kit for the detection of TADG-15 protein
PCT/US2000/029095WO2001029056A1 (en)	1999-10-20	2000-10-20	Tadg-15: an extracellular serine protease overexpressed in carcinomas

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
EP07118615ADivisionEP1887082A3 (en)	1999-10-20	2000-10-20	TADG-15: An extracellular serine protease overexpressed in carcinomas

Publications (2)

Publication Number	Publication Date
EP1226150A1 EP1226150A1 (en)	2002-07-31
EP1226150A4true EP1226150A4 (en)	2005-05-25

Family

ID=23669632

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP07118615AWithdrawnEP1887082A3 (en)	1999-10-20	2000-10-20	TADG-15: An extracellular serine protease overexpressed in carcinomas
EP00973739AWithdrawnEP1226150A4 (en)	1999-10-20	2000-10-20	TADG-15: A CARCINOMA-OVEREXPRISED EXTRACELLULAR SERINE PROTEASE

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EP07118615AWithdrawnEP1887082A3 (en)	1999-10-20	2000-10-20	TADG-15: An extracellular serine protease overexpressed in carcinomas

Country Status (6)

Country	Link
EP (2)	EP1887082A3 (en)
JP (1)	JP2003512036A (en)
AU (1)	AU774106B2 (en)
CA (1)	CA2388450C (en)
MX (1)	MXPA02004046A (en)
WO (1)	WO2001029056A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7022100B1 (en)	1999-09-03	2006-04-04	A-Med Systems, Inc.	Guidable intravascular blood pump and related methods
US7795211B2 (en)*	2000-02-22	2010-09-14	Board Of Trustees Of The University Of Arkansas	Methods for the early diagnosis of ovarian cancer
US7157596B2 (en)	2000-09-08	2007-01-02	Dendreon Corporation	Inhibitors of serine protease activity of matriptase or MTSP1
US7019019B2 (en)	2002-12-23	2006-03-28	Dendreon Corporation	Matriptase inhibitors and methods of use
US7572444B2 (en)	2004-12-20	2009-08-11	Amgen Fremont Inc.	Binding proteins specific for human matriptase
GB0611116D0 (en)*	2006-06-06	2006-07-19	Oxford Genome Sciences Uk Ltd	Proteins
EP2185933B1 (en)*	2007-08-07	2015-10-07	Oxford Biotherapeutics Ltd.	Matriptase protein and uses thereof
US9309325B2 (en)	2009-05-07	2016-04-12	The Regents Of The University Of California	Antibodies and methods of use thereof
US8455200B2 (en)	2009-10-15	2013-06-04	Traxxsson, Llc	Measurement of PKA for cancer detection
AU2011299088B2 (en)	2010-09-09	2015-12-24	Traxxsson, Llc	Combination methods of diagnosing cancer in a patient
WO2014120555A1 (en)	2013-01-31	2014-08-07	The Regents Of The University Of California	Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
KR20160079818A (en)	2013-11-25	2016-07-06	옥스포드 바이오테라퓨틱스 리미티드	Antibodies anti matriptase for the treatment of cancer
US9272027B1 (en)	2014-09-08	2016-03-01	The United States Of America As Represented By The Secretary Of The Air Force	Francisella tularensis live vaccine strains and methods of use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998041656A1 (en)*	1997-03-19	1998-09-24	The Board Of Trustees Of The University Of Arkansas	Compositions and method for the early diagnosis of ovarian cancer
WO1999036550A2 (en)*	1998-01-16	1999-07-22	Incyte Pharmaceuticals, Inc.	Human protease molecules
WO1999042120A1 (en)*	1998-02-20	1999-08-26	The Board Of Trustees Of The University Of Arkansas	Tadg-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09149790A (en)*	1995-09-29	1997-06-10	Suntory Ltd	New serine protease
WO2000042201A2 (en)*	1999-01-11	2000-07-20	Incyte Pharmaceuticals, Inc.	Human peptidases
JP4778617B2 (en)*	1999-03-12	2011-09-21	ジョージタウンユニバーシティ	Matriptase, serine protease and their applications

2000
- 2000-10-20WOPCT/US2000/029095patent/WO2001029056A1/enactiveIP Right Grant
- 2000-10-20CACA2388450Apatent/CA2388450C/ennot_activeExpired - Fee Related
- 2000-10-20EPEP07118615Apatent/EP1887082A3/ennot_activeWithdrawn
- 2000-10-20JPJP2001531854Apatent/JP2003512036A/enactivePending
- 2000-10-20MXMXPA02004046Apatent/MXPA02004046A/enactiveIP Right Grant
- 2000-10-20AUAU12215/01Apatent/AU774106B2/ennot_activeCeased
- 2000-10-20EPEP00973739Apatent/EP1226150A4/ennot_activeWithdrawn

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998041656A1 (en)*	1997-03-19	1998-09-24	The Board Of Trustees Of The University Of Arkansas	Compositions and method for the early diagnosis of ovarian cancer
WO1999036550A2 (en)*	1998-01-16	1999-07-22	Incyte Pharmaceuticals, Inc.	Human protease molecules
WO1999042120A1 (en)*	1998-02-20	1999-08-26	The Board Of Trustees Of The University Of Arkansas	Tadg-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references ofWO0129056A1*

Also Published As

Publication number	Publication date
CA2388450A1 (en)	2001-04-26
EP1226150A1 (en)	2002-07-31
CA2388450C (en)	2013-02-12
EP1887082A3 (en)	2008-06-11
AU774106B2 (en)	2004-06-17
AU1221501A (en)	2001-04-30
MXPA02004046A (en)	2002-10-11
JP2003512036A (en)	2003-04-02
WO2001029056A1 (en)	2001-04-26
EP1887082A2 (en)	2008-02-13

Publication	Publication Date	Title
DK1181017T3 (en)	2003-07-14	metalloprotease
DE50012572D1 (en)	2006-05-24	DETERGENT MIXTURES
DE60125859D1 (en)	2007-02-22	polisher
DE60129488D1 (en)	2007-09-06	display
ID30007A (en)	2001-11-01	DRESS ON USE
DK0979240T3 (en)	2004-07-26	serine protease
EP1207511A4 (en)	2006-08-16	DISPLAY
ID29885A (en)	2001-10-18	SERINA PROBLEM PROTEASE
DE60108470D1 (en)	2005-02-24	Transparent soap bar
DE60038157D1 (en)	2008-04-10	CONSTRUCTION MACHINE
DE50105593D1 (en)	2005-04-21	grinder
NO20032390L (en)	2003-07-22	Serotonergic agents
EP1226150A4 (en)	2005-05-25	TADG-15: A CARCINOMA-OVEREXPRISED EXTRACELLULAR SERINE PROTEASE
DE50105754D1 (en)	2005-05-04	grinder
NO20030095L (en)	2003-03-10	grinder
DE60122236D1 (en)	2006-09-28	polisher
FI20000508L (en)	2000-12-18	Crusher
DE60144430D1 (en)	2011-05-26	SUBTILASE VARIANTS
DE50104735D1 (en)	2005-01-13	grinder
DE50011864D1 (en)	2006-01-19	surfactant mixtures
ATA1322000A (en)	2000-11-15	IRRIGATION MACHINE
ITBO20000623A0 (en)	2000-10-26	SANDER MACHINE
DE50115725D1 (en)	2011-01-13	grinding machine
FI20002338L (en)	2002-04-25	Method in the working machine
DE50100300D1 (en)	2003-07-17	Twin grinding

Legal Events

Date	Code	Title	Description
2002-06-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text:ORIGINAL CODE: 0009012
2002-07-31	17P	Request for examination filed	Effective date:20020419
2002-07-31	AK	Designated contracting states	Kind code of ref document:A1 Designated state(s):AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-07-31	AX	Request for extension of the european patent	Free format text:AL;LT;LV;MK;RO;SI
2005-05-25	A4	Supplementary search report drawn up and despatched	Effective date:20050406
2007-05-16	17Q	First examination report despatched	Effective date:20050928
2008-03-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-04-16	18D	Application deemed to be withdrawn	Effective date:20071030

Movatterモバイル変換